Dxc800
The DXC800 is a fully automated clinical chemistry analyzer designed for high-throughput testing in clinical laboratories. It offers fast, precise, and reliable analysis of a wide range of clinical chemistry parameters.
Lab products found in correlation
68 protocols using dxc800
Serum Cholesterol and Triglycerides Analysis
Evaluating Kidney Injury Biomarkers in SYNERGY
Kidney function using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula will also be measured [22 ].
In addition, urinary Kim-1, a marker of kidney tubule damage, will be measured from midstream urine collections before and after each intervention [47 (link)]. Samples will be stored at −80°C, followed by analysis using a commercially available sandwich ELISA according to the manufacturer’s instructions (USCN Life Sciences, Wuhan, PRC). Significant changes in Kim-1 have been achieved in a 6 week dietary intervention study indicating the feasibility of Kim-1 as a sensitive marker in SYNERGY [48 (link)].
Birth Cohort and ALT Levels for Anti-HCV Testing
Serum Extraction and Biochemical Analysis
Maternal and Fetal Biochemical Profiling
Serum Biomarkers in Inflammatory Bowel Disease
Comprehensive Clinical Data Collection for PCI Patients
Gestational Diabetes Mellitus Screening
Venous blood samples were drawn after a minimum of a 10-h overnight fast during 24-28th gestational weeks. Serum biochemical parameters were measured using a Beckman DXC800 automatic biochemical analyser. Haemoglobin A1C (HbA1c) levels were measured using high-performance liquid chromatography (TOSOH HLC-723 G7, Japan), and insulin levels were determined using an insulin detection kit and its reagent (Roche Diagnostics, Germany).
One-step 75 g OGTTs were performed during 24-28th gestational weeks. Fasting and postload blood glucose and insulin levels were measured at 0, 60, and 120 min. GDM was diagnosed according to the 2013 World Health Organization diagnostic criteria: fasting blood glucose ≥5.1 mmol/L,1-h OGTT blood glucose ≥10.0 mmol/L, or 2-h OGTT blood glucose ≥8.5 mmol/L.
All participants were inpatients before delivery. Weight gain during pregnancy was collected, and primary adverse outcomes were confirmed by experienced obstetricians. The natural rupture of foetal membranes before the first stage of labour was diagnosed as PROM. All subjects had delivered and finished follow-up by December 2019.
Fasting Biomarker Quantification in Serum
Serum ghrelin and PYY levels were quantified using enzyme-linked immunosorbent assay (ELISA) kits (Jianglaibio, Shanghai, China). Serum triglycerides, total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, and insulin levels were measured with a fully automatic immunoanalyzer (Beckman DXC 800, Fullerton, CA, USA). Fasting plasma glucose level (FPG) was measured by dry chemical method.
Blood Biomarker Quantification Protocol
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!